Position available on Executive Board – Vice Chair of NOTCH
Role to commence from March 2025
A great opportunity to get more involved with NOTCH and guide our future direction! The vice chair will work closely with the incoming NOTCH chair (Mary Denholm) to progress and coordinate the work of NOTCH, which includes 4-6 weekly meetings, Project support and involvement in NOTCH events (Symposium and AGM).
The vice chair will progress to the role of chair with an inteānded change-over date in November 2025 (at which point a new vice chair will be recruited
To retain our existing balance, ideally this person would be a medical oncology trainee but if you are a clinical oncology trainee and keen to get involved, please get in touch!
ā
Please email uk.notch@nhs.net to ask any questions and express your interest
ā
We are pleased to invite you and any interested colleagues to register for a free ticket for:
Medicine at the Crick
The good, the bad, and the ugly: tissue somatic evolution in ageing and disease
Thursday 13th March 2025, 14:00-18.00
Hybrid event taking place virtually and in person, organised by The Francis Crick Institute, London
Our Medicine at the Crick event series showcases major advances in biomedical science and raises awareness of the medical implications of major scientific advances. Interested members of the wider UK biomedical community are invited to attend.
More about the event
This 16th edition of Medicine at the Crick will be hosted by Prof Francesca Ciccarelli (The Francis Crick Institute) and Dr Ilaria Malanchi (The Francis Crick Institute).
What maintains tissue homeostasis over time and when is the balance disrupted, triggering disease initiation?
In this Medicine at the Crick event we will explore these fundamental questions with world leaders. We will discuss the roles of somatic mutations in ageing and review the interactions between mutant cells and the surrounding stroma to understand what intrinsic and extrinsic factors lead mutant cells to cause disease.
ā
Programme
ā
Speakers include: Professor Cedric Blanpain (Université Libre de Bruxelles), Professor Phil Jones (Wellcome Sanger Institute), Professor Sabine Werner (ETH Zurich), Dr Maria P. Alcolea (University of Cambridge), Dr Foad Rouhani (The Francis Crick Institute)
Lectures will be followed by a Q&A panel discussion and a networking reception for in person attendees.
You can find a more detailed programme here
ā
Registration
Please find attached a poster for the event. Visit our webpages for further details including a more detailed programme, and register via Eventbrite to order a free virtual or in person ticket for the event.
Please send any questions to: medicine-at-crick@crick.ac.uk
ā
āāā
BONUS MENTORING SCHEME
The British Oncology Network of Undergraduate Societies are seeking medical and clinical oncology trainees and consultants to partake in their mentoring scheme for undergraduate medical students or early-career junior doctors for the next academic year.
ā
To find out more, please click on the button bellow.
ā
To apply, please follow the following link:
https://forms.gle/rGqRwky5W7169tsL7
ā
RCR CLINICAL ONCOLOGY TRAINEE RESEARCH NETWORK
The trainee members of the Clinical Oncology Academic Committee provide monthly email updates on external funding, fellowship and lectureship opportunities and relevant meetings and training courses in order to encourage the number and quality of research-active and academic Clinical Oncologists to members of the Clinical Oncology Trainee Research Network.
ā
How to get involved
ā
To register for your interest and subscribe to these monthly updates, click on the button below.
INDUSTRY RESEARCH FELLOWSHIP OPPORTUNITY WITH BIONTECH FOR ONCOLOGY TRAINEES
ā
In July 2023, BioNTech signed a long-term partnership agreement with the UK, with the goal of working together to develop new cancer therapies for the benefit of NHS patients. This includes an accelerated clinical trials program supported by NIHR and NHS England, agreeing to deliver 10,000 cancer vaccines to patients in the UK by 2030. BioNTech have a diverse portfolio of trials in cancer vaccines and next generation immunotherapies, currently being brought to the UK. With this in mind, it is an exciting time to be involved in these latest technologies and trials and this role offers a unique opportunity to be at the forefront of the national cancer vaccine advance.
BioNTech are expanding their UK team and it is an exciting time to be involved in the national cancer vaccine advance. Research interest and experience is important, and whilst previous industry experience is a bonus it is certainly not required. The role as a medical science liaison includes serving as the link between trial investigators and BioNTech, but also supporting global trials teams with activities from clinical development and early protocol discussion, to overseeing regulatory approvals and inputting on general strategy for the UK partnership and initiatives such as the Cancer Vaccine Launchpad.
This role is primarily remote, and ideal as an out of programme experience for medical or clinical oncologists. Duration is flexible, but a minimum of 1 year (2-3 years recommended.)
ā
If interested, please contact rosie.mew@biontech.co.uk